EG23861A - Intermediates and process for preparing olanzapine - Google Patents

Intermediates and process for preparing olanzapine

Info

Publication number
EG23861A
EG23861A EG98697A EG98697A EG23861A EG 23861 A EG23861 A EG 23861A EG 98697 A EG98697 A EG 98697A EG 98697 A EG98697 A EG 98697A EG 23861 A EG23861 A EG 23861A
Authority
EG
Egypt
Prior art keywords
intermediates
preparing olanzapine
olanzapine
preparing
Prior art date
Application number
EG98697A
Other languages
English (en)
Inventor
Charle A Bunnell
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21832120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG23861(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of EG23861A publication Critical patent/EG23861A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EG98697A 1996-09-23 1997-09-23 Intermediates and process for preparing olanzapine EG23861A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2648796P 1996-09-23 1996-09-23

Publications (1)

Publication Number Publication Date
EG23861A true EG23861A (en) 2007-11-18

Family

ID=21832120

Family Applications (1)

Application Number Title Priority Date Filing Date
EG98697A EG23861A (en) 1996-09-23 1997-09-23 Intermediates and process for preparing olanzapine

Country Status (36)

Country Link
US (1) US6020487A (fr)
EP (1) EP0831098B1 (fr)
JP (2) JP2001500877A (fr)
KR (1) KR100560015B1 (fr)
CN (1) CN1122036C (fr)
AR (1) AR013838A1 (fr)
AT (1) ATE209208T1 (fr)
AU (1) AU719441B2 (fr)
BR (1) BR9712100A (fr)
CA (1) CA2265712C (fr)
CO (1) CO4910140A1 (fr)
CZ (1) CZ299248B6 (fr)
DE (1) DE69708428T2 (fr)
DK (1) DK0831098T3 (fr)
EA (1) EA001642B1 (fr)
EG (1) EG23861A (fr)
ES (1) ES2166051T3 (fr)
HK (1) HK1009807A1 (fr)
HU (1) HU226484B1 (fr)
ID (1) ID27275A (fr)
IL (1) IL128962A (fr)
IN (1) IN187156B (fr)
MY (1) MY125565A (fr)
NO (1) NO323980B1 (fr)
NZ (1) NZ334448A (fr)
PE (1) PE110398A1 (fr)
PL (3) PL194565B1 (fr)
PT (1) PT831098E (fr)
RS (1) RS49598B (fr)
SI (1) SI0831098T1 (fr)
SV (1) SV1997000081A (fr)
TR (1) TR199900640T2 (fr)
TW (1) TW470746B (fr)
UA (1) UA59371C2 (fr)
WO (1) WO1998012199A1 (fr)
ZA (1) ZA978515B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK2502003A3 (en) * 2000-08-31 2004-03-02 Reddys Lab Ltd Dr Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
US6740753B2 (en) 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
EP1440074A1 (fr) * 2001-10-29 2004-07-28 Dr. Reddy's Laboratories Ltd. Dihydrate-ii d'olanzapine: son procede de preparation et son utilisation
AU2002367119A1 (en) 2001-12-24 2003-07-15 Sun Pharmaceutical Industries Limited Crystalline form I of 2-methyl-4-(4-methyl-1-piperazinyl) 10H thieno [2,3-b][1,5]benzodiazepine
AU2003243153A1 (en) * 2002-04-23 2003-11-10 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
US7297789B2 (en) 2002-05-31 2007-11-20 Sandoz, Inc. Process of preparation of olanzapine form I
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
US7323459B2 (en) * 2002-12-24 2008-01-29 Teva Pharmaceutical Industries Ltd. Crystal forms, methods for their preparation and method for preparation of olanzapine
US20070148218A1 (en) * 2003-11-18 2007-06-28 Gordon Ryan D Olanzapine containing transdermal drug delivery compositions
ATE397611T1 (de) * 2003-12-22 2008-06-15 Teva Pharma Verfahren zur herstellung von olanzapin
ATE504588T1 (de) 2004-01-27 2011-04-15 Synthon Bv Stabile salze von olanzapin
US20070072845A1 (en) * 2004-02-19 2007-03-29 Davuluri Rammohan Rao Process for the preparation of olanzapine form 1 useful as antipsychotic drug
DE05783995T1 (de) * 2004-07-14 2007-10-11 Shasun Chemicals and Drugs Ltd., Chennai Verbessertes verfahren zur herstellung von form i aus olanzapin
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
ES2303462B1 (es) * 2004-09-06 2009-06-05 Shasun Chemicals And Drugs Limited Nuevo procedimiento para la preparacion de una forma polimorfica i de olanzapina farmaceuticamente pura.
AU2005307797B2 (en) * 2004-11-16 2011-06-02 Alkermes Pharma Ireland Limited Injectable nanoparticulate olanzapine formulations
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
CA2591644A1 (fr) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Nouvelles methodes de synthese de la forme-i de l'olanzapine
EP2486913A1 (fr) 2011-02-14 2012-08-15 Labtec GmbH Formulation de film oral à désintégration rapide pour olanzapine
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンｉｉ型結晶の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines
CA2002596A1 (fr) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates de beta-lactam antibiotiques
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
NZ247703A (en) * 1992-05-29 1995-07-26 Lilly Industries Ltd Thienobenzdiazepine derivatives and medicaments thereof
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
UA56184C2 (uk) * 1996-09-23 2003-05-15 Елі Ліллі Енд Компані Поліморфна модифікація оланзапіну дигідрату d, фармацевтична композиція та спосіб лікування психотичного стану

Also Published As

Publication number Publication date
EP0831098B1 (fr) 2001-11-21
UA59371C2 (uk) 2003-09-15
EP0831098A3 (fr) 1998-04-29
CZ99099A3 (cs) 1999-11-17
YU15599A (sh) 2001-12-26
DE69708428D1 (de) 2002-01-03
PL332482A1 (en) 1999-09-13
IN187156B (fr) 2002-02-16
NO991382L (no) 1999-03-22
EP0831098A2 (fr) 1998-03-25
NO991382D0 (no) 1999-03-22
HU226484B1 (en) 2009-03-02
HUP0000066A2 (hu) 2000-06-28
PE110398A1 (es) 1999-01-14
ZA978515B (en) 1999-03-23
AU719441B2 (en) 2000-05-11
KR20000048520A (ko) 2000-07-25
CA2265712C (fr) 2006-10-31
CN1122036C (zh) 2003-09-24
AU4484197A (en) 1998-04-14
IL128962A (en) 2003-01-12
HUP0000066A3 (en) 2000-11-28
AR013838A1 (es) 2001-01-31
SV1997000081A (es) 1999-01-14
PT831098E (pt) 2002-04-29
PL196069B1 (pl) 2007-12-31
JP2001500877A (ja) 2001-01-23
EA001642B1 (ru) 2001-06-25
RS49598B (sr) 2007-06-04
DK0831098T3 (da) 2002-05-21
CO4910140A1 (es) 2000-04-24
HK1009807A1 (en) 1999-06-11
CN1234802A (zh) 1999-11-10
CA2265712A1 (fr) 1998-03-26
JP2009242407A (ja) 2009-10-22
CZ299248B6 (cs) 2008-05-28
PL194565B1 (pl) 2007-06-29
ES2166051T3 (es) 2002-04-01
PL196068B1 (pl) 2007-12-31
TW470746B (en) 2002-01-01
MY125565A (en) 2006-08-30
KR100560015B1 (ko) 2006-03-15
US6020487A (en) 2000-02-01
IL128962A0 (en) 2000-02-17
BR9712100A (pt) 1999-08-31
NZ334448A (en) 2000-08-25
WO1998012199A1 (fr) 1998-03-26
EA199900326A1 (ru) 1999-08-26
TR199900640T2 (xx) 1999-06-21
NO323980B1 (no) 2007-07-30
SI0831098T1 (en) 2002-04-30
DE69708428T2 (de) 2002-07-04
ATE209208T1 (de) 2001-12-15
ID27275A (id) 2001-03-22

Similar Documents

Publication Publication Date Title
AP9901444A0 (en) Erythrommycins and process for their preparation
HUP9800208A3 (en) Omega-cycloalkyl-prostaglandin e2-derivatives and process for preparing them
GB9609441D0 (en) Process
EG23861A (en) Intermediates and process for preparing olanzapine
HU9702508D0 (en) Vitronectin-receptor-antagonists and process for producing them
EP0880388A4 (fr) Procede d'etherification-hydrogenation
HU9702509D0 (en) Vitronectin-receptor-antagonists and process for producing them
ZA9711523B (en) Continuous fermentation process
HU9602105D0 (en) Intermediate and process for making
IL118992A0 (en) Process and intermediates for preparing norbenzomorphan derivatives
HUP0001813A3 (en) Process for preparing eprosartan and intermediates
HUP0003019A3 (en) Process for preparing 4-substituted-1h-indole-3-glyoxamides and their intermediates
PL321699A1 (en) Tempering process
GB9602046D0 (en) Process
HUP0001444A3 (en) Process for preparing carboxamido-4-azasteroids and their intermediates
GB2319771B (en) Process
HUP0002522A3 (en) Process for making benzisothiazolin-3-ones
EP0990639A4 (fr) Procede de production de n-cyclopropylanilines et intermediaires utilises dans ce procede
HUP9904112A3 (en) Process for preparing amidines
GB2316403B (en) Process
GB9708810D0 (en) Milk-shakes and process for making them
HUP9801594A3 (en) Novel seco-azalides and process for preparing them
IL141354A0 (en) Hydroxyphenyl-hydroximinomethyl-dioxazines and process for preparing them
GB9610470D0 (en) Article making method
HUP9903692A3 (en) Process for making dihydropyrimidinones